IBM's new healthcare biz gets to work on personalized cancer treatments

IBM ($IBM) is unleashing Watson on healthcare. After scoring a trifecta of big-name deals--with Apple ($AAPL), Medtronic ($MDT) and Johnson & Johnson ($JNJ)--the tech heavyweight's brand-new healthcare business unit says it will team up with 14 top cancer centers to turn genetic data into personalized patient treatments. More from FiercePharmaMarketing